State Street
CRBU icon

State Street’s Caribou Biosciences CRBU Stock Holding History

State Street’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87M Buy
1,632,914
+1,209,651
+286% +$2.39M ﹤0.01% 3218
2026
Q1 		$804K Hold
423,263
– – ﹤0.01% 3539
2025
Q4 		$673K Buy
423,263
+37,000
+10% +$77.7K ﹤0.01% 3608
2025
Q3 		$900K Buy
386,263
+28,100
+8% +$53K ﹤0.01% 3535
2025
Q2 		$451K Sell
358,163
-1,283,018
-78% -$1.26M ﹤0.01% 3635
2025
Q1 		$1.5M Sell
1,641,181
-16,380
-1% -$21.3K ﹤0.01% 3337
2024
Q4 		$2.64M Buy
1,657,561
+39,318
+2% +$79.1K ﹤0.01% 3228
2024
Q3 		$3.17M Buy
1,618,243
+2,664
+0.2% +$5.46K ﹤0.01% 3158
2024
Q2 		$2.65M Sell
1,615,579
-4,731,742
-75% -$15.1M ﹤0.01% 3205
2024
Q1 		$32.6M Buy
6,347,321
+1,227,655
+24% +$7.57M ﹤0.01% 1945
2023
Q4 		$29.3M Sell
5,119,666
-233,723
-4% -$1.16M ﹤0.01% 1993
2023
Q3 		$25.6M Buy
5,353,389
+4,283,243
+400% +$26.6M ﹤0.01% 2021
2023
Q2 		$4.55M Sell
1,070,146
-2,285,146
-68% -$10.3M ﹤0.01% 3037
2023
Q1 		$17.8M Buy
3,355,292
+156,399
+5% +$974K ﹤0.01% 2313
2022
Q4 		$20.1M Buy
3,198,893
+803,423
+34% +$7.15M ﹤0.01% 2244
2022
Q3 		$25.3M Buy
2,395,470
+1,597,870
+200% +$14.9M ﹤0.01% 2050
2022
Q2 		$4.33M Buy
797,600
+54,578
+7% +$417K ﹤0.01% 3165
2022
Q1 		$6.82M Buy
743,022
+330,074
+80% +$3.48M ﹤0.01% 3029
2021
Q4 		$6.23M Buy
412,948
+129,359
+46% +$2.52M ﹤0.01% 3135
2021
Q3 		$6.77M Buy
+283,589
New +$6.93M ﹤0.01% 3078

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street's CRBU Position: Q2 2026 in Review

State Street increased its Caribou Biosciences (CRBU) stake by 286% in Q2 2026, buying an estimated $2.39M and bringing the position to 1,632,914 shares worth $2.87M. The position accounts for ﹤0.01% of the portfolio, ranked #3218.

State Street first reported a position in CRBU in Q3 2021 and has held it in 20 quarters since. The position peaked at $32.6M in Q1 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • State Street held 1,632,914 shares of Caribou Biosciences worth $2.87M as of Q2 2026.
  • State Street bought 1,209,651 Caribou Biosciences shares in Q2 2026, an estimated $2.39M.
  • Caribou Biosciences made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3218 holding.
  • State Street first reported a position in Caribou Biosciences in Q3 2021 and has held it in 20 quarters since.
  • State Street's Caribou Biosciences position peaked at $32.6M in Q1 2024.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.